FRANKLYN G. PRENDERGAST - 08 Jun 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4
Filing time
12 Jun 2023, 16:51:18 UTC
Previous filing
12 Sep 2022
Next filing
04 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +6,500 $0.000000 6,500 08 Jun 2023 Common Stock 6,500 $4.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the options shall vest 25% every quarter after the grant date.